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Suprabasal Spongiosis in Acute Eczematous
Dermatitis: cFLIP Maintains Resistance of Basal
Keratinocytes to T-Cell-Mediated Apoptosis
Nicole Armbruster1, Axel Trautmann1, Eva-Bettina Bro¨cker1, Martin Leverkus2 and Andreas Kerstan1
In acute eczematous dermatitis, keratinocyte (KC) apoptosis caused by dermis-infiltrating, activated T cells plays
a crucial pathogenetic role in the development of spongiosis, the histopathological hallmark of acute eczema.
Remarkably, T-cell-mediated apoptosis of single KC, as well as spongiosis, is located predominantly in
suprabasal epidermal layers, suggesting that antiapoptotic mechanisms protect basal KC. The cellular Flice-
inhibitory protein (cFLIP) is known to block apoptotic CD95-signaling, and may therefore account for such a
protection of basal KC. HaCaT KCs retrovirally transduced with the long form of cFLIP were effectively protected
against T-cell-mediated apoptosis in KC monolayer/CD4þ T-cell cocultures. In situ correlation of cFLIP protein
expression and KC apoptosis in lesional eczematous skin showed a highly restricted expression of cFLIP in basal
KC, whereas cleaved caspase-3 (as a surrogate marker of apoptosis) was detected predominantly in suprabasal
epidermal layers. Thus, the modulation of the CD95 signaling pathway by the cell-intrinsic caspase-8 inhibitor
cFLIP in basal KC may explain the spatial localization of spongiosis in suprabasal epidermal layers, and provides
new insights into the pathogenesis of spongiosis formation in eczematous dermatitis.
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INTRODUCTION
Eczematous dermatitis is a T-cell-mediated inflammatory skin
disease, where activated T cells may harm epidermal
keratinocytes (KCs) by direct cell–cell contact or secreted
proinflammatory cytokines, accounting for at least some of
the features of spongiosis formation, the typical epidermal
pathology of eczema (Trautmann et al., 2000; Akiba et al.,
2002). We have previously shown that activated T cells
infiltrating the skin induce apoptosis of single KC, as shown in
situ, in the lesional skin of atopic dermatitis (AD) and allergic
contact dermatitis (ACD). Interestingly, in these studies,
apoptosis of single KC was detected predominantly in
suprabasal epidermal layers, concomitant with suprabasal
spongiosis formation. This spatial localization of KC apopto-
sis raises the question about the mechanism that might
protect basal KC against T-cell-mediated apoptosis. Resting
human KCs express low levels of CD95 that are upregulated
by IFN-g. In T-cell–KC cocultures, KCs undergo apoptosis
induced by supernatants of activated T cells, direct contact
with activated T cells, and artificial CD95 triggering through
a soluble CD95 ligand (Trautmann et al., 2000).
The CD95 signaling pathway is characterized by the
sequential activation of caspases (Kumar, 2007). In this context,
activation of the effector caspase-3 represents one of the key
points in the transmission of the CD95 death signal leading to
the biochemical and morphological changes of apoptosis
(Lavrik et al., 2005). The cellular Flice-inhibitory protein (cFLIP)
blocks the CD95 signaling pathways through the inhibition of
the initiator caspases-8/-10 within the death-inducing signaling
complex, thereby preventing the activation of caspase-3 (Peter
and Krammer, 2003), and was previously shown to be
expressed in primary human KCs in vitro when compared with
spontaneously transformed HaCaT KCs (Leverkus et al., 2000).
In this study, we show that HaCaT KCs, ectopically
expressing the long form of cFLIP (cFLIPL) in the T-cell–KC
coculture system, are protected against T-cell-mediated
apoptosis. In biopsy specimens of acute eczematous derma-
titis (AD/ACD), we found that cFLIP expression is highly
restricted to the basal KC layer. Conversely, epidermal
caspase-3 cleavage was almost exclusively detected in
suprabasal epidermal layers close to areas of spongiosis. In
contrast, expression of cFLIP in the basal epidermal layer
could not protect KC from apoptosis in the biopsy specimen
of lichen planus (LP), most likely through dominance of
granzyme B positive cytotoxic effector T cells in the lichenoid
infiltrate of this disease (Wenzel et al., 2006).
In summary, these findings support the hypothesis
that cFLIP may contribute to the resistance of basal KCs to
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death-receptor-induced, T-cell-mediated apoptosis in ecze-
matous dermatitis, and provide an explanation for the spatial
restriction of spongiosis to suprabasal epidermal layers.
RESULTS
T-cell-mediated keratinocyte apoptosis
In vitro, crystal violet stainings showed that incubation of
HaCaT KCs with activated T cells or their supernatants,
respectively, partially destroyed the HaCaT monolayer,
mimicking spongiosis formation in vivo (Figure 1a). Activated
T cells with direct contact to the HaCaT monolayer, as well
as supernatants of activated T cells, induced significant
HaCaT KC apoptosis compared with HaCaT cells cultured
alone at day 2 (Figure 1b). Purified CD4þ T cells were
stimulated for 24 hours with a combination of anti-CD2/-
CD3/-CD28mAb, and then cells and supernatants were
separately incubated with a blocking CD95L-specific mAb.
In parallel, the sensitivity of cultured HaCaT KCs to CD95-
mediated cell death was determined by crosslinking of CD95
with recombinant CD95L. As shown in Figure 1c, continuous
CD95L blockade prevented cell death induced by activated T
cells and supernatants to levels comparably achieved by the
pan-caspase inhibitor z-VAD. Moreover, artificial CD95
crosslinking of HaCaT cells showed their sensitivity to
CD95-mediated apoptosis. These findings show that under
both coculture conditions, allowing or omitting direct
cell–cell contact, HaCaT KC apoptosis induced by anti-
CD2/-CD3/-CD28mAb-activated T cells is mainly mediated
through CD95L.
cFLIP inhibits T-cell-mediated apoptosis of keratinocytes
The intracellular protein cFLIP interferes with death ligand-
induced apoptosis at the death-inducing signaling complex in
KCs (Leverkus et al., 2000; Wachter et al., 2004). To evaluate
the impact of upstream caspase inhibition in our experimental
system, we first established cFLIPL-expressing HaCaT KCs by
retroviral transduction (Figure 2a and b and Figure S1,
Supplementary Materials and Methods). Polyclonal cFLIPL-
expressing populations of HaCaT cells expressed comparable
levels of CD95 as determined by flow cytometric analysis
(Figure 2c), but were highly resistant to CD95-induced apoptosis
when compared with control-infected cells (Figure 2d), indicat-
ing the functionality of ectopically expressed cFLIPL. Most
importantly, a pronounced inhibition of apoptosis was observed
when cFLIPL-expressing HaCaT KCs were exposed to activated T
cells as well as their supernatants. In fact, the frequency of dead
cells was comparable with ‘‘spontanous’’ apoptosis observed in
vector control cells. However, we cannot formally exclude that
other death receptor pathways, such as tumor necrosis factor,
might contribute to the slight increment of the frequency of dead
HaCaT KCs in cocultures with activated T cells or their
supernatants. Nonetheless, these experiments show that cFLIPL
is capable of inhibiting T-cell-mediated KC apoptosis in vitro.
Reciprocal epidermal caspase-3 cleavage and cFLIP expression
in acute eczematous dermatitis
The histological hallmark of eczematous disorders consists of
a marked KC pathology. During eczematous inflammation,
acantholysis and spongiosis in suprabasal epidermal layers
may proceed to frank vesicle formation (Figure 3a and b). As
caspase-3 is the prime executioner caspase of apoptosis
(Lavrik et al., 2005), we next investigated the in situ cleavage
of caspase-3 in eczematous dermatitis using an mAb that
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Figure 1. T-cell-mediated keratinocyte (KC) apoptosis. (a) Signs of HaCaT KC
injury after coculture with activated T cells. Intact monolayer of HaCaT KC
was cultured without additions, with resting T cells, or with their supernatant,
respectively. The HaCaT monolayer after 2 days coculture with activated T
cells or their supernatant is destroyed. Crystal violet staining of KC cultured in
96-well plates. (b) HaCaT KC apoptosis in coculture with stimulated CD4þ T
cells, supernatant from stimulated CD4þ T cells or unstimulated controls.
Cell death was analyzed as described in Materials and Methods. Data from
three independent experiments performed in triplicates are shown. Error bars
indicate SD. **Po0.01, act.¼ activated, rest.¼ resting. (c) Role of CD95-
mediated KC apoptosis in cocultures with activated T cells. HaCaT–T-cell
cocultures and detection of apoptosis were performed as described in (b). The
pan-caspase inhibitor z-VAD and a neutralizing anti-CD95L mAb (aCD95L)
block T-cell-mediated HaCaT KC apoptosis. Susceptibility of HaCaT cells to
CD95-mediated cell death was determined through artificial CD95 triggering
(soluble CD95L). Error bars indicate SD calculated from three independent
experiments performed in triplicates. **Po0.01. SPNT¼ supernatant.
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full-length, caspase-3. In all biopsy specimens tested (AD/
ACD), cleaved caspase-3 was detected in single suprabasal
KCs within areas of spongiosis, whereas healthy or non-
lesional skin showed no signal (Figure 3c and d). In cases
with spongiotic vesicle formation, single KCs positive for
cleaved caspase-3 were seen in the suprabasal epidermal
layers close to the vesicle (Figure 3e and f). In contrast, cFLIP
expression in healthy/non-lesional skin and acute eczema-
tous dermatitis (AD/ACD) was restricted to basal epidermal
KCs (Figure 3g and h).
Apoptosis of basal keratinocytes in lichen planus
The characteristic histopathological findings of LP are the
interface dermatitis, consisting of a dense subepidermal
band-like lymphocytic infiltrate with vacuolization of the
basal epidermal layer (Figure 4a and b). Analysis of cleaved
caspase-3 in biopsy specimens of LP showed single apoptotic
KC positive in the basal epidermal layer (Figure 4c and d).
Interestingly, expression of antiapoptotic cFLIP in KCs at the
dermal–epidermal junction was unchanged (Figure 4e and f),
suggesting a mechanism of cell death different to CD95
signaling in LP. Accordingly, it has been reported that
cytotoxic effector T cells expressing granzyme B are the
predominant subset of lymphocytes in LP (and in other
dermatoses characterized by an interface dermatitis, Wenzel
and Tuting, 2008, and Figure S2). Therefore, in contrast to
acute eczematous dermatitis, the perforin/granzyme pathway
may bypass the antiapoptotic effect of cFLIP in LP (Wenzel
et al., 2006).
DISCUSSION
T-cell-mediated apoptosis of single KCs is a key feature of
epidermal pathology in acute eczematous dermatitis. Inter-
estingly, in eczema, spongiosis is predominantly located in
suprabasal epidermal layers, suggesting an antiapoptotic
mechanism protecting basal KCs. CD95 is slightly upregu-
lated on KCs throughout all epidermal layers in eczematous
dermatitis as compared with healthy skin (Trautmann et al.,
2000; Simon et al., 2006). Thus, differential CD95 expression
may basically account for the increased susceptibility of KCs
to CD95-mediated apoptosis in eczema, but does not explain
the apoptosis resistance of basal KCs. The differential
expression of pro- and antiapoptotic factors, which may
influence the susceptibility to CD95-mediated apoptosis,
might provide an explanation for the restriction of spongiosis
to suprabasal epidermal layers. Epidermal cFLIP expression
was readily detected in basal KCs of healthy skin (Figure 3g),
and this expression pattern was also observed in eczematous
dermatitis (Figure 3h), suggesting that basal epidermal KC
may be protected by cFLIP from T-cell-mediated cell death in
eczematous dermatitis. This concept is supported by Bach-
mann et al. (2001) who showed that cFLIP is strongly
expressed in the basal epidermal layer and squamous-cell
carcinoma, thereby providing a tumor escape mechanism
through an enhanced resistance to death-receptor-mediated
apoptosis. However, future experiments using primary KCs
with repressed cFLIP expression have to clarify the precise
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Figure 2. Retroviral infection of HaCaT keratinocytes (KCs) with cFLIPL. (a) Green fluorescent protein expression (GFP) of HaCaT KC retrovirally transduced
with bicistronic expression vectors containing the empty vector or cFLIPL. (b) Expression of retrovirally transduced cFLIPL was confirmed by western blot
analysis. b-Tubulin serves as a loading control. (c) Unaltered CD95 expression of empty vector or cFLIPL-transduced HaCaT cells as determined by flow
cytometry. (d) cFLIPL protects HaCaT KCs from T-cell-induced apoptosis. HaCaT cells transduced with empty vector or vector carrying cFlipL were cocultured
and stimulated through CD95, as described in Figure 1b and c. The results shown represent three experiments performed in triplicates. Error bars depict SD.
**Po0.01, ***Po0.001, act.¼ activated, rest.¼ resting.
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The restricted expression of cFLIP to basal epidermal KCs
may be crucial for skin homeostasis/renewal. In this
respect, inhibition of death-receptor-mediated apoptosis
in the course of inflammatory skin diseases might
ensure survival of the basal epidermal layer (including
stem cells). However, under certain inflammatory settings
in skin diseases involving (autoreactive) cytotoxic T cells,
apoptosis of basal epidermal KC spotlights the epidermal
histopathology. As shown for LP and other dermatoses
going along with an interface dermatitis, cytotoxic granzyme
B-expressing T cells directly attack basal epidermal KCs
(Wenzel and Tuting, 2008), thereby overriding the protective
role of cFLIP. It has been suggested that pathogenetically
type I IFNs (IFN-a/b) play an important role in the recruitment
of cytotoxic lymphocytes to the skin in interface dermatitis,
whereas in eczematous dermatitis a type II IFN (IFN-g)
secreted by activated CD4þ T cells is one of the major
cytokines promoting skin pathology. Accordingly, using
in vitro T-cell–KC cocultures, apoptosis of KC is inhibited in
the presence of a neutralizing IFN-g mAb, pinpointing
IFN-g as a central cytokine in eczematous skin inflammation
(Trautmann et al., 2000). Future studies will have to clarify
if such an inhibition of type I IFNs abolishes KC pathology
in LP.
The importance of the marked resistance of cFLIP-
expressing HaCaT KCs against T-cell-mediated apoptosis is
further stressed by recent work that showed a CD95-induced
proinflammatory response of KCs (Farley et al., 2006, 2008;
Leverkus and Trautmann, 2006). CD95–CD95L interactions
were shown to activate the transcription factor NF-kB that is
critical for the CD95L-induced activation of inflammatory
genes, such as IL-8. Furthermore, CD95L-stimulated secretion
of EGF ligands led to the para-/autocrine activation of EGFR
and the downstream activation of ERK, which was shown to
mediate some of the CD95L-induced inflammatory re-
sponses. Importantly, in these studies caspase inhibitors
blocked the execution of the death program, but did not
suppress proinflammatory gene expression. Thus, a reason-
able candidate for intracellular signal deviation upon CD95
triggering could be cFLIP (Park et al., 2005). However, in
contrast to the studies by Farley et al. (2006, 2008) using
pharmacological peptide inhibitors of caspases, the
physiological inhibitor cFLIP appears to inhibit death-
receptor-mediated NF-kB activation and gene induction in
KCs (Kreuz et al., 2004; Wachter et al., 2004). Nonetheless,
the precise role of cFLIP as a molecular switch that allows
CD95 either to mediate apoptosis or to activate the non-
apoptotic mitogen-activated protein kinases and NF-kB
pathways remains controversial, and may depend on the
signaling strength. A recent study showed that upon moderate
triggering of CD95, cFLIP was efficiently recruited to the
death-inducing signaling complex, leading to the inhibition
of caspase-8 activation and thereby promoting survival
signals (Lavrik et al., 2007). To add more complexity,
studies in which the caspase-8 induced cleavage product
p43 of cFLIP was ectopically expressed induced NF-kB
(Kataoka and Tschopp, 2004). Furthermore, recent studies
showed that cFLIP may act in concert with FADD and
caspase-8 and link CD95 to non-apoptotic pathways (Park
et al., 2005). Thus, cFLIP seems to be an enhancer of NF-kB
activation (thereby promoting survival and proliferation) in
some contexts and an inhibitor in others. This argues for a
highly cell-type-specific signaling capability of cFLIP. In any
case, further studies have to clarify the potential role of cFLIP
Figure 3. Features of acute eczematous dermatitis. (a) and (b) Representative
histological findings of acute eczematous dermatitis (here: AD). A dense
subepidermal T-cell-rich inflammatory infiltrate, and marked suprabasal
epidermal akantolytic and spongiotic changes progress to vesicle formation.
Hematoxylin/eosin staining. (c–f) Suprabasal caspase-3 cleavage in
eczematous dermatitis. (c) Healthy skin as a negative control. (d) Eczematous
skin (here: AD) with moderate spongiosis. Cleaved caspase-3 (p17) is
predominantly detected in suprabasal layers. (e) p17 is expressed at the side
and at the bottom of spongiotic vesicle (SV) formation (here: ACD). Panel (f) is
a blow-up of panel (e) and highlights single KC positive for p17 expression. (g)
Restricted expression of cFLIP to the basal layer in healthy and (h) lesional
skin of acute eczematous dermatitis (here: ACD). Scale bars¼100 mm.
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in proinflammatory CD95-signaling in human KCs (Leverkus
et al., 2008).
In conclusion, we show that cFLIP protects basal KCs
against T-cell-mediated apoptosis exerted in eczematous
dermatitis, thereby facilitating the rapid healing of an
uncomplicated eczema due to the survival of basal KCs.
The knowledge of this molecular basis is pivotal in under-
standing the development of spongiotic pathology in eczema,
and opens a future for more focused therapeutic applications.
MATERIALS AND METHODS
Subjects
Four incisional skin biopsies were taken from positive nickel patch
tests (2þ according to the International Contact Dermatitis Research
Group), LP and AD. Additionally, three cases of AD with acute
exacerbation and three cases with LP were drawn from the files of
our Department. For comparison, biopsies from non-lesional skin of
three patients with positive nickel patch tests and normal skin of
three healthy, non-atopic individuals were obtained. Informed
consent was obtained from all subjects, and the study was approved
by the Ethical Committee Board of the University of Wu¨rzburg,
Germany. The study was conducted according to the Declaration of
Helsinki Principles.
Antibodies and reagents
The following mAb were used for cell culture, immunohistochem-
istry, and flow cytometry: neutralizing anti-CD95L (NOK-2, Becton
Dickinson, Heidelberg, Germany), anti-cleaved caspase-3 (5A1,
New England Biolabs, Frankfurt, Germany), anti-cFLIP (G-11, Santa
Cruz Biotechnology, Heidelberg, Germany), and allophycocyanin
labeled anti-CD95 (DX2, Miltenyi Biotec, Bergisch Gladbach,
Germany). Appropriate isotype controls were from Becton Dickinson
or Dako (Hamburg, Germany).
Keratinocyte and T-cell culture
The spontaneously transformed KC line HaCaT was kindly provided
by Professor Petra Boukamp (DKFZ, Heidelberg, Germany) and
cultured as described (Boukamp et al., 1988). Mononuclear cells
were isolated by Ficoll (Linaris, Wertheim, Germany) density
gradient centrifugation of peripheral venous blood of healthy
volunteers. CD4þ cells were negatively selected using the MACS
system (CD4þ isolation Kit II) according to the manufacturer’s
instructions (Miltenyi Biotec). Purified CD4þ cells resuspended in
RPMI 1640 (supplemented with 10% fetal calf serum, 2mM
L-glutamine, 100U/ml penicillin, and 100mg/ml streptomycin; all
from PAN Biotech, Aidenbach, Germany) were costimulated (106/
ml) in six-well dishes with a combination of soluble anti-CD2 (4B2
and 6G4, each 0.5 mgml1), anti-CD3 (UCHT1, 1mgml1), and anti-
CD28 (CD28.2, 1mgml1) mAb (Trautmann et al., 2000). After
24 hours, cells were harvested and washed twice with medium
before the initiation of T-cell–KC cocultures. In parallel, supernatants
were retained and cleared by centrifugation.
Keratinocyte–T-cell cocultures
For coculture experiments, HaCaT cells were cultured in six-well
plates in the presence or absence of activated CD4þ T cells at a ratio
of 3:1. For studying the effects of T cells on KCs, T-cell supernatants
were collected, diluted 1:2 with supplemented RPMI 1640, and
added to HaCaT cells in six-well plates.
Retroviral transduction
The pCFG5-IEGZ retroviral vector containing complementary DNA
inserts of cFLIPL (Geserick et al., 2008) was used for infection of
HaCaT KCs. Briefly, the amphotrophic producer cell line jNX was
transfected with 10 mg of the retroviral vectors by calcium phosphate
precipitation. Cell-culture supernatants containing viral particles
were generated by incubation of producer cells with HaCaT medium
(DMEM containing 10% fetal calf serum) overnight, as described
(Diessenbacher et al., 2008). Following filtration, the culture
supernatant was added to HaCaT cells seeded in six-well plates
24 hours earlier in the presence of 1 mgml1 of polybrene. HaCaT
cells were centrifuged for 3 hours at 32 1C, and viral particle
containing the supernatant was subsequently replaced by fresh
medium. After 10–14 days, the recovery of bulk-infected cultures in
the presence of Zeocin (300 mgml1) was carried out. FACS analysis
for green fluorescent protein expression and western blot analysis
(Figure 2a and b) was performed on polyclonal expanded cells to
confirm ectopic cFLIPL expression.
Induction, inhibition, and detection of apoptosis
Sensitivity of HaCaT KC to CD95-mediated apoptosis was assessed
by incubation with a soluble Flag-tagged fusion protein of CD95L
Figure 4. Features of lichen planus (LP). (a) and (b) Representative
histological findings of LP. Interface dermatitis with hydropic degeneration of
the basal epidermis and a dense, band-like lympho-cytic infiltrate
accompanied by acanthosis, hypergranulosis, and keratosis. Note the single
apoptotic KCs in the basal epidermal layer. Hematoxylin/eosin staining. (c)
and (d) Single KC positive for cleaved caspase-3 (arrows) are found in the
basal epidermal layer in areas of KC damage. (e) and (f) Unperturbed
expression of cFLIP in the basal epidermal layer in LP. Scale bars¼ 100 mm.
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(0.1 mgml1 Axxora, Lo¨rrach, Germany), which was crosslinked
through an anti-Flag mAb (1mgml1; Enhancer, Axxora). Inhibition
of CD95-induced apoptosis was tested with preincubation of
supernatants and activated T cells with a neutralizing anti-CD95L
mAb. For the protease inhibition assay, cells were preincubated for
1 hour with 40 mM of z-VAD-fmk (Z-Val-Ala-Asp-fluoromethyl
ketone, Sigma-Aldrich, Schnelldorf, Germany). After 48 hours
incubation, KCs were harvested and resuspended in annexin-V-
binding buffer (0.01M HEPES pH 7.4, 0.14M NaCl, 2.5mM CaCl2)
containing FITC-labeled annexin V (Becton Dickinson) and 7-
actinomycin D (Sigma-Aldrich). After 15minutes at 4 1C in the dark,
the samples were diluted in buffer and immediately analyzed in a
FACSCanto flow cytometer (Becton Dickinson). In the flow
cytometry setting, HaCaT and T cells were gated according to
forward and side scatter. Crystal violet staining of attached and
viable cells was performed 2 days after incubation with activated T
cells and their supernatant, respectively, in 96-well plates.
Immunohistology
The tissue samples were placed in Tissue-Tek OCT compound
(Sakura Finetek Europe BV, Zoeterwoude, The Netherlands) and
stored at 140 1C. Cryostat sections (4–5mm) were prepared on
silanized slides (Superfrost plus, Langenbrinck, Teningen, Germany).
After air drying, the sections were fixed in acetone (for detection of
cFLIP) or 10% buffered formalin solution (for detection of cleaved
caspase-3) for 10minutes at 4 1C. The sections were then incubated
with mouse anti-cFLIP mAb (10 mg/ml) or rabbit anti-cleaved
caspase-3 mAb (0.5 mg/ml) at 4 1C overnight. This was followed by
incubation with a combination of biotin-conjugated goat-anti-
mouse/goat-anti-rabbit IgG (Dako), and subsequently streptavidin-
conjugated horseradish-peroxidase (Dako) at room temperature for
1 hour. Incubation with the peroxidase-specific substrate 3-amino-9-
ethylcarbazole (Sigma-Aldrich) was used for visualization, with
hematoxylin counterstaining.
Alternatively, detection of cleaved caspase-3 was evaluated on
paraffin-embedded specimens of AD (3 ) or LP (3 ) drawn from
the files of our Department. Briefly, 5mm paraffin sections were
dewaxed and rehydrated with xylene and graded alcohols, followed
by unmasking of antigen epitopes by boiling in citrate buffer pH 6.0
(Dako) for 10minutes. After cooling to room temperature, endogen-
ous peroxidase was quenched with hydrogen peroxide. Thereafter,
cleaved caspase-3 was detected as described above. For control
purposes, the primary mAb was replaced by an irrelevant isotype-
matched mAb or rabbit IgG, which consistently yielded negative
results. The stained sections were evaluated by light microscopy
(Axiophot, Carl Zeiss, Jena, Germany).
Western blot
Cell lysates were prepared essentially as described before (Leverkus
et al., 2003). Lysates of 5 105 cells per lane were separated
by SDS-PAGE on 4–12% NuPAGE Bis-Tris gradient gels (Invitrogen,
Karlsruhe, Germany) and transferred to nitrocellulose membranes.
Subsequently,
membranes were probed with mAb to cFLIP (NF-6, Axxora)
or to b-tubulin (Sigma-Aldrich), as indicated followed by the
appropriate secondary antibody-peroxidase conjugate, and devel-
oped using the ECL detection system (Amersham Biosciences,
Freiburg, Germany).
Statistical analyses
Where indicated, data were subjected to unpaired t-test (GraphPad
Prism 5.0; GraphPad). Values of Po0.05 were considered to be
significant.
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